Home/Filings/4/0000950170-24-069860
4//SEC Filing

Mason Michael 4

Accession 0000950170-24-069860

CIK 0001503802other

Filed

Jun 5, 8:00 PM ET

Accepted

Jun 6, 4:03 PM ET

Size

4.8 KB

Accession

0000950170-24-069860

Insider Transaction Report

Form 4
Period: 2024-06-04
Mason Michael
SVP, CFO & Treasurer
Transactions
  • Sale

    Common Stock

    2024-06-04$0.99/sh652$645398,104 total
Footnotes (1)
  • [F1]This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.

Documents

1 file

Issuer

Karyopharm Therapeutics Inc.

CIK 0001503802

Entity typeother

Related Parties

1
  • filerCIK 0001514291

Filing Metadata

Form type
4
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 4:03 PM ET
Size
4.8 KB